NEW YORK (GenomeWeb) – EKF Diagnostics Holdings today announced that the potential purchase of the company's Point-of-Care business by Chinese firm Jinjing has fallen through.

The firm had also received a non-binding preliminary proposal from an unrelated third party for its Clinical Chemistry and Molecular Diagnostics businesses in August, but that proposal has been withdrawn.

Instead, former Alere CEO Ron Zwanziger will now take over as chairman of EKF, while current chairman David Evans will become deputy chairman.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.